Compare AJANTA PHARMA with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALEMBIC LTD AJANTA PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 21.4 66.1 32.4% View Chart
P/BV x 3.8 2.3 160.9% View Chart
Dividend Yield % 0.9 0.4 214.8%  

Financials

 AJANTA PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ALEMBIC LTD
Mar-18
AJANTA PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,42272 1,974.9%   
Low Rs89834 2,647.8%   
Sales per share (Unadj.) Rs233.54.7 4,967.7%  
Earnings per share (Unadj.) Rs44.06.1 720.3%  
Cash flow per share (Unadj.) Rs52.26.2 835.1%  
Dividends per share (Unadj.) Rs9.000.20 4,500.0%  
Dividend yield (eoy) %0.80.4 205.5%  
Book value per share (Unadj.) Rs255.140.7 627.3%  
Shares outstanding (eoy) m88.02267.03 33.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.011.3 44.1%   
Avg P/E ratio x26.48.7 304.1%  
P/CF ratio (eoy) x22.28.5 262.3%  
Price / Book Value ratio x4.51.3 349.1%  
Dividend payout %20.53.3 624.7%   
Avg Mkt Cap Rs m102,08114,139 722.0%   
No. of employees `0006.8NA-   
Total wages/salary Rs m4,307207 2,076.7%   
Avg. sales/employee Rs Th3,022.6NM-  
Avg. wages/employee Rs Th633.4NM-  
Avg. net profit/employee Rs Th569.1NM-  
INCOME DATA
Net Sales Rs m20,5541,255 1,637.5%  
Other income Rs m211370 56.9%   
Total revenues Rs m20,7651,625 1,277.5%   
Gross profit Rs m5,664111 5,098.4%  
Depreciation Rs m72138 1,906.9%   
Interest Rs m122 682.4%   
Profit before tax Rs m5,143442 1,164.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,27324 5,315.2%   
Profit after tax Rs m3,8701,630 237.4%  
Gross profit margin %27.68.9 311.4%  
Effective tax rate %24.85.4 456.6%   
Net profit margin %18.8129.8 14.5%  
BALANCE SHEET DATA
Current assets Rs m11,8121,867 632.7%   
Current liabilities Rs m3,776591 638.8%   
Net working cap to sales %39.1101.6 38.5%  
Current ratio x3.13.2 99.0%  
Inventory Days Days7794 82.1%  
Debtors Days Days8274 111.0%  
Net fixed assets Rs m14,3981,791 804.0%   
Share capital Rs m175534 32.8%   
"Free" reserves Rs m22,27710,324 215.8%   
Net worth Rs m22,45210,858 206.8%   
Long term debt Rs m741 16.0%   
Total assets Rs m26,96211,591 232.6%  
Interest coverage x444.3260.9 170.3%   
Debt to equity ratio x00 7.7%  
Sales to assets ratio x0.80.1 703.9%   
Return on assets %14.414.1 102.3%  
Return on equity %17.215.0 114.8%  
Return on capital %23.015.2 151.1%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m10,68219 55,060.3%   
Fx outflow Rs m2,102264 796.7%   
Net fx Rs m8,580-244 -3,510.3%   
CASH FLOW
From Operations Rs m3,748236 1,589.4%  
From Investments Rs m-2,228-224 994.6%  
From Financial Activity Rs m-1,475-27 5,543.6%  
Net Cashflow Rs m45-15 -305.4%  

Share Holding

Indian Promoters % 73.8 64.0 115.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 0.2 775.0%  
FIIs % 7.6 9.7 78.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 26.1 65.1%  
Shareholders   20,968 54,701 38.3%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  J.B.CHEMICALS  DR. REDDYS LAB  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Oct 16, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - PANACEA BIOTECH COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS